These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21621597)

  • 21. Preparation and cell activities of lactosylated curdlan-triornithine nanoparticles for enhanced DNA/siRNA delivery in hepatoma cells.
    Wang X; Qi Y; Liu L; Ganbold T; Baigude H; Han J
    Carbohydr Polym; 2019 Dec; 225():115252. PubMed ID: 31521309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. siRNA delivery using nanocarriers - an efficient tool for gene silencing.
    Khurana B; Goyal AK; Budhiraja A; Arora D; Vyas SP
    Curr Gene Ther; 2010 Apr; 10(2):139-55. PubMed ID: 20353386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid nanoparticles for short interfering RNA delivery.
    Leung AK; Tam YY; Cullis PR
    Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use.
    Parashar D; Rajendran V; Shukla R; Sistla R
    Eur J Pharm Sci; 2020 Jan; 142():105159. PubMed ID: 31747618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cationic lipids and polymers mediated vectors for delivery of siRNA.
    Zhang S; Zhao B; Jiang H; Wang B; Ma B
    J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient nanocarriers of siRNA therapeutics for cancer treatment.
    Subhan MA; Torchilin VP
    Transl Res; 2019 Dec; 214():62-91. PubMed ID: 31369717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers.
    Scholz C; Wagner E
    J Control Release; 2012 Jul; 161(2):554-65. PubMed ID: 22123560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of polymeric nanoparticles for siRNA delivery to down-regulate the expressions of exogenous and endogenous target genes.
    Huang W; Lv M; Gao ZG; Jin MJ; Xu YJ; Yu XD; Jin ZH; Yin XZ
    Pharmazie; 2012 Aug; 67(8):676-80. PubMed ID: 22957431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2008 Mar; 99(4):975-85. PubMed ID: 17929316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of copolymers of N-isopropylacrylamide and 2-dimethyl(aminoethyl)methacrylate in nonviral and adenoviral vectors for gene delivery to nasopharyngeal carcinoma.
    Moselhy J; Sarkar S; Chia MC; Mocanu JD; Taulier N; Liu FF; Wu XY
    Int J Nanomedicine; 2007; 2(3):461-78. PubMed ID: 18019844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric siRNA gene delivery - transfection efficiency versus cytotoxicity.
    Kargaard A; Sluijter JPG; Klumperman B
    J Control Release; 2019 Dec; 316():263-291. PubMed ID: 31689462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymeric vectors for ocular gene delivery.
    Tamboli V; Mishra GP; Mitrat AK
    Ther Deliv; 2011 Apr; 2(4):523-36. PubMed ID: 21858246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
    Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
    Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
    Dilnawaz F
    Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
    Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
    Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.
    Fattal E; Bochot A
    Int J Pharm; 2008 Dec; 364(2):237-48. PubMed ID: 18619528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of plasmid-lipid complexes for direct intratumoral injection.
    Kotipatruni RP; Nagaraju GP
    Methods Mol Biol; 2014; 1139():467-76. PubMed ID: 24619700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.
    Ball RL; Bajaj P; Whitehead KA
    Sci Rep; 2018 Feb; 8(1):2178. PubMed ID: 29391566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.